Feedback / Questions
ATNM-400 - Actinium
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-presents-new-preclinical-data-demonstrating-potent-anti-tumor-activity-of-atnm-400-across-multiple-breast-cancer-subtypes-including-hormone-receptor-positive-triple-negative-and-tamoxifen--and-her2-thera-302640194.html
Dec 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next